Physician profile
Ehsan A Khan
NPI 1598149734
$3,969.53
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,530 · 2020: $715 · 2021: $778 · 2022: $844 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $896.07 | 2019-2020 | |
| Stryker Corporation | $593.71 | 2019-2021 | |
| Tactile Systems Technology INC | $548.10 | 2019-2022 | |
| Horizon Therapeutics Plc | $436.96 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $320.27 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $208.35 | 2021-2022 | |
| Misonix INC | $139.43 | 2019-2021 | |
| Wright Medical Technology, INC. | $118.97 | 2020 | |
| Access Pro Medical, LLC | $107.17 | 2022 | |
| Medtronic, INC. | $89.77 | 2022 | |
| Smith+Nephew, INC. | $72.76 | 2019-2022 | |
| Bioventus LLC | $68.67 | 2020-2021 | |
| Organogenesis INC. | $56.26 | 2020 | |
| Nabriva Therapeutics, Plc | $43.18 | 2022 | |
| Abbvie INC. | $37.43 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $33.69 | 2022-2023 | Nuzyra |
| Trice Medical, INC. | $29.86 | 2021 | |
| Kerecis Limited | $25.55 | 2021 | |
| Heron Therapeutics, INC. | $22.90 | 2021 | |
| Bsn Medical INC | $22.13 | 2020 | |
| Fidia Pharma USA INC. | $21.55 | 2019 | |
| Depuy Synthes Sales INC. | $21.48 | 2022 | |
| Averitas Pharma INC. | $21.31 | 2023 | Qutenza |
| Paragon 28, INC. | $17.25 | 2021 | |
| Kci USA, INC. | $16.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehsan Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.